ArticleNature reviews. Clinical oncology2013
Haematological cancer: Nilotinib reduces emergence of BCR-ABL mutations in CML.
Vanessa MarchesiPubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleNature reviews. Clinical oncology2013
Vanessa MarchesiPubMed ↗Publisher ↗
No numbers read from the abstract.